Strides Pharma hits fresh 52-week high after tentative US FDA nod for Dolutegravir tablets

The stocks of the company were trading over 9.50 per cent higher at Rs 513 per share, as of 11:23 am, on BSE.

Related Keywords

Bengaluru ,Karnataka ,India ,Singapore ,United States ,Barun Kumar ,United States Food Drug Administration ,Strides Pharma Global Pte ,Tivicay Tablets Of Viiv Healthcare Company ,Strides Pharma ,Strides Pharma Global Pte Limited ,United States Food ,Drug Administration ,Reference Listed Drug ,Tivicay Tablets ,Viiv Healthcare ,Managing Director ,Executive Chairperson ,Strides Pharma Stocks ,Bse ,Nse ,Indian Stock Market ,Business News ,Stock Rallies ,52 Week High ,Financial Performance ,Nifty ,